Newsroom

Press Releases

January 8, 2026
SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs
Press Release,
December 8, 2025
SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A
Press Release,
November 5, 2025
SonoThera Presents New Data at ASN Kidney Week 2025 Demonstrating Full-Length Col4a5 Gene Expression Using Ultrasound Mediated Gene Delivery in Treating X-Linked Alport Syndrome
Press Release,
October 7, 2025
SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy
Press Release,
May 6, 2025
SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A
Press Release,
December 2, 2024
SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver
Press Release,
November 14, 2024
SonoThera Presents New Data at the ASGCT Breakthroughs in Muscular Dystrophy Meeting on Ultrasound-Mediated Gene Delivery (UMGD) to Heart and Skeletal Muscle
Press Release,
November 11, 2024
SonoThera to Present Preclinical Data on Ultrasound-Mediated Gene Delivery Platform to the Heart at the American Heart Association (AHA) Scientific Sessions 2024
Press Release,
October 22, 2024
SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy Delivery Platform
Press Release,
June 23, 2024
SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment
Press Release,
April 30, 2024
SonoThera™ to Present Four Abstracts at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Press Release,
June 27, 2023
SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
Press Release,
May 15, 2023
SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform
Press Release,
May 11, 2023
SonoThera™ to Present Preclinical Data on Use of Its Ultrasound-Guided Gene Therapy Platform at the 2023 ASGCT Annual Meeting
Press Release,
February 27, 2023
SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison® and Sonazoid® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform
Press Release,
December 5, 2022
SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development
Press Release,

In the News

January 5, 2024
SonoThera’s CEO Ken Greenberg interviewed by Wilson Sonsini’s Dustin Luettgen in the latest edition of the Life Sciences Report
News,
January 3, 2024
SonoThera featured in the BioSpace NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
News,
December 6, 2023
Illumina Ventures spotlights SonoThera – The Next Leap in Genetic Medicine
News,
July 31, 2023
SonoThera featured in the Wall Street Journal’s Future of Everything story on using ultrasound and microbubbles to enable therapeutic delivery to challenging organs
News,
December 12, 2022
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform
News,
December 5, 2022
Endpoints News Features SonoThera’s Series A Raise of $60.75M
News,
Press Inquiries media

Press Inquiries

Members of the media may contact SonoThera Corporate Communications at media@sonothera.com

Inquiries about our Clinical Research

Contact Us